pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 766 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
EBC-129
Pancreatic Ductal Adenocarcinoma
Agency for Science, Technology and Research
0 catalysts
Phase 1
EG-001
Idiopathic Interstitial Pneumonia (IIP)
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 1
EG-009
Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 1
← prev
page 9 of 26
next →
131
Pain89
Neurology1
EG-301
Dry (Atrophic) Macular Degeneration
Shenzhen Evergreen Therapeutics Co Ltd
0 catalysts
Phase 1
EL-22
Obesity
Northstrive Biosciences Inc
0 catalysts
Phase 1
ELVN-001
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$ELVNEnliven Therapeutics, Inc.
0 catalysts
Phase 1
ENS-002
Atopic Dermatitis (Atopic Eczema)
Concerto Biosciences Inc
0 catalysts
Phase 1
ENV-308
Obesity
Enveda Biosciences Inc
0 catalysts
Phase 1
ENV-6946
Inflammatory Bowel Disease
Enveda Biosciences Inc
0 catalysts
Phase 1
EO-2002
Corneal Edema
Emmecell LLC
0 catalysts
Phase 1
ER-100
Non-Arteritic Anterior Ischemic Optic Neuropathy
Life Biosciences Inc.
0 catalysts
Phase 1
ERAS-4001
Solid Tumor
$ERASErasca, Inc.
0 catalysts
Phase 1
ERSM-5404
Colorectal Cancer
Hibercell Inc
0 catalysts
Phase 1
EV68-228-N
Flaccid Paralysis
KBio Inc
0 catalysts
Phase 1
EVOLVE-104
Anal Cancer
EvolveImmune Therapeutics Inc
0 catalysts
Phase 1
Exosome-Based Vaccine
Coronavirus Disease 2019 (COVID-19)
$CAPRCAPRICOR THERAPEUTICS, INC.
0 catalysts
Phase 1
FB-101
Amyotrophic Lateral Sclerosis
1st Bio Therapeutics Inc
0 catalysts
Phase 1
FBHRS-001
Atrial Fibrillation
FB HRS LLC
0 catalysts
Phase 1
FHL-301
Parkinson's Disease
Forest Hills Partners Hong Kong Ltd
0 catalysts
Phase 1
FID-022
Solid Tumor
Fulgent Pharma LLC
0 catalysts
Phase 1
FMT-XBI-302
Graft Versus Host Disease (GVHD)
Shenzhen UnknownBio Biotechnology Co Ltd
0 catalysts
Phase 1
FORX-428
Metastatic Breast Cancer
FoRx Therapeutics AG
0 catalysts
Phase 1
FPI-2068
Metastatic Colorectal Cancer
Fusion Pharmaceuticals Inc
0 catalysts
Phase 1
FS-120
Advanced Malignancy
invoX Pharma Ltd
0 catalysts
Phase 1
FT-522
B-Cell Non-Hodgkin Lymphoma
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-576
Refractory Multiple Myeloma
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-825
Colorectal Cancer
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
FT-836
Breast Cancer
$FATEFATE THERAPEUTICS INC
0 catalysts
Phase 1
G-207
Anaplastic Astrocytoma
Treovir LLC
0 catalysts